Drug Type AAV based gene therapy |
Synonyms oncolytic adenovirus therapy expressing p53 + GM-CSF + B7.1(Tianjin Hi-Tech/The Institute of Radiation Medicine), oncolytic adenovirus therapy expressing p53 + GM-CSF + CD28 costimulator(Tianjin Hi-Tech/The Institute of Radiation Medicine) |
Target |
Action agonists, modulators |
Mechanism CD28 agonists(T-cell-specific surface glycoprotein CD28 agonists), CD80 modulators(Cluster of differentiation 80 modulators), p53 modulators(Tumor protein p53 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | IND Application | China | 02 Dec 2004 |